Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma.

Béranger LuezaAnne AupérinCharlotte RigaudThomas G GrossMarta PillonRafael F DelgadoAnne UyttebroeckGladstone A A BurkeJózsef ZsírosMonika CsókaMathieu SimoninCatherine PatteVéronique Minard-ColinJulia Bonastre

Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2023)

ClinicalTrials.gov identifier: NCT01516580.

Keyphrases

diffuse large b cell lymphoma
hodgkin lymphoma
study protocol
clinical trial
phase iii
phase ii
chronic lymphocytic leukemia
open label